GSK's profits up by 12%, but US business continues to falter
23 July 2009
Sita Shah
Please Login to read the full article.
23 July 2009
Sita Shah
GlaxoSmithKline's second-quarter profits rose by 12% to £1.46 billion, helped by the weak sterling – profits were down by 7% at constant exchange rates (CER). EPS rose by 15% (–4% at CER) to 28.3 pence.
GSK's second-quarter net sales rose by 15% to £6.75...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Gilenya and Tasigna drive new product growth at Novartis
- GSK to close three research units, open four more amid hopes for sales growth in 2012
- GSK back to growth in Q3 as headwinds drop and Japan focus pays off
- Sanofi results: Genzyme doesn't paper over cracks, as emerging markets top US and EU
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
